As of March 2024 Regulus Therapeutics has a market cap of $0.18 Billion. This makes Regulus Therapeutics the world's 7006th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.18 B | 628.37% |
2023 | $25.88 M | 12.2% |
2022 | $23.07 M | -49.82% |
2021 | $45.98 M | -46.37% |
2020 | $85.73 M | 358.29% |
2019 | $18.7 M | 127.96% |
2018 | $8.2 M | -92.41% |
2017 | $0.10 B | -9.21% |
2016 | $0.11 B | -74.07% |
2015 | $0.45 B | -41.5% |
2014 | $0.78 B | 154.23% |
2013 | $0.30 B | 36.8% |
2012 | $0.22 B |
On Mar 27th, 2024 the market cap of Regulus Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Sanofi SNY | $123.67 B | 65,495.68% | ๐ซ๐ท France |
Biogen BIIB | $31.44 B | 16,579.42% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $107.68 B | 57,013.38% | ๐บ๐ธ USA |
AstraZeneca AZN | $211.63 B | 112,148.82% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | $87.82 B | 46,484.19% | ๐ฌ๐ง UK |
Sangamo Therapeutics
SGMO | $0.12 B | -32.52% | ๐บ๐ธ USA |
Dicerna Pharmaceuticals DRNA | $2.97 B | 1,479.35% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $19.44 B | 10,213.35% | ๐บ๐ธ USA |